Urology

Higher levels of leisure-time physical activity after cancer diagnosis were associated with lower cancer mortality in survivors of several tumour types.

Salvage focal therapy delivers similar 10-year survival to surgery in radiorecurrent prostate cancer, with significantly fewer perioperative complications.

Modified water vapour thermal therapy significantly improved symptoms, urinary flow, and quality of life in men with large-volume BPH, with low complication rates.

Automated urinary incontinence screening in primary care increased diagnoses and pelvic floor therapy referrals among more than 72,000 women in a US quality-improvement study.

A systematic review reveals how gut microbiota changes, inflammation, and intestinal barrier dysfunction may influence benign prostatic hyperplasia development.

A 20-year cohort study shows men with low baseline PSA face minimal prostate cancer risk, supporting personalised screening strategies using PSA and PSA density.

New evidence shows PSA and Ki-67 tumour expression may help predict progression and guide treatment decisions in metastatic castration-sensitive prostate cancer.

Malabsorptive bariatric surgery shows higher kidney stone risk than restrictive procedures, based on post-operative 24-hour urine chemistry findings.

A multicentre prospective trial shows the artificial urinary sphincter delivers high continence rates, improved quality of life, and a low revision rate in men.

Spending more time outdoors was linked to higher testosterone levels and lower odds of low testosterone in adult men, independent of lifestyle and metabolic factors.

A propensity-weighted study compares micro-ultrasound with MRI fusion biopsy for detecting clinically significant prostate cancer in men with MRI-visible lesions.

Urinary cell-free microRNAs may enable non-invasive detection of aggressive bladder cancer subtypes, offering a rapid alternative to tissue-based molecular profiling.

Early urine output patterns in female ICU patients with genitourinary infections are strongly linked to 28-day mortality and acute kidney injury risk.

A 12-year follow-up study shows urinary symptoms worsen over time after vaginal delivery, but long-term severity and quality-of-life impact are similar with or without OASIS.

PSA derivatives may help reduce unnecessary prostate MRI in men with prior negative biopsy, while maintaining detection of clinically significant cancer.

SGLT2 inhibitors may slow prostate cancer progression in men on hormone therapy, reducing therapy failure. Find out how these diabetes drugs could help.

A new meta-analysis links elevated neutrophil-to-lymphocyte ratio to higher risk and progression of diabetic nephropathy, highlighting its potential as a clinical biomarker.

Plasma presepsin outperformed traditional biomarkers in predicting 28-day mortality among patients with UTI-related severe infection in emergency care.

A retrospective study identifies clinical, laboratory, and imaging predictors of sepsis and mortality after nephrostomy tube placement in cancer patients.

Baseline eosinophil levels and early blood count changes may help predict survival and response in metastatic renal cell carcinoma patients treated with nivolumab.

A new study identifies APOC1 and NOP16 as potential prostate cancer biomarkers that may improve early diagnosis and complement current PSA testing.

A combined ultrasound and CT model accurately predicts spontaneous stone passage in ureteral stones ≤10 mm, supporting safer conservative management decisions.

Robot-assisted radical prostatectomy was linked to significantly fewer short-term complications than open surgery in a large nationwide French cohort study.

A randomised trial shows transcutaneous tibial nerve stimulation reduces catheter-related bladder discomfort and improves early recovery after urologic surgery.

A nasal pressure technique significantly reduces pain during urinary catheterisation, offering a simple, non-pharmacological option for patient comfort in the ED.

A large NHANES analysis shows the red cell distribution width-to-albumin ratio is strongly associated with diabetic kidney disease risk in adults with diabetes.

New research suggests routine blood-based inflammation markers could help predict which men with enlarged prostates are likely to develop more severe symptoms.

Researchers report that yoga and general exercise deliver similar sleep outcomes for women managing urinary incontinence.

A new rapid, low-cost sequencing method delivers four-hour UTI diagnosis with high accuracy, detecting pathogens missed by routine tests and improving antibiotic decision-making.

Escalating antimicrobial resistance has been identified among urology inpatients in a new study from a Turkish tertiary centre, highlighting urgent stewardship needs.

A large Norwegian study shows that higher cardiorespiratory fitness is linked to a significantly lower long-term risk of urinary tract, bladder, and kidney cancers.

A new study highlights oxidative and neuroimmune changes in diabetic urinary incontinence, identifying 4-HNE as a key biomarker differentiating diabetic and non-diabetic cases.

An automated MRI decision aid (ProAI) improves detection of clinically significant prostate cancer, boosting accuracy and cutting radiology workload by 32%.

Sequential therapy shows poorer outcomes in upper tract urothelial carcinoma than bladder cancer, highlighting the need for more effective first-line treatments.

This study reports early outcomes of percutaneous kidney-sparing surgery for upper tract urothelial carcinoma, highlighting feasibility, recurrence rates, and follow-up needs.

Men receiving a penile prosthesis during prostate cancer surgery showed faster sexual recovery and better satisfaction than those treated years later.

Smoking and hysterectomy raise the risk of vaginal mesh erosion after POP surgery, according to a new systematic review and meta-analysis.

Certain cancer drugs, including CDK4/6, EGFR, VEGFR, and BRAF inhibitors, may raise the risk of progressive kidney dysfunction over two years.

Researchers identify ALYREF as a dual-role biomarker in bladder cancer, linked to aggressive disease yet improved immunotherapy response.

Study shows in-office transperineal prostate biopsy under local anaesthesia achieves high diagnostic accuracy without antibiotics.

Remimazolam offers a rapid onset and offset, cardiovascular stability, and organ-independent metabolism, making it especially suitable for older patients.

New research shows no clear link between diet, urinary pH, and recurrent UTIs in postmenopausal women. Learn more about this pilot study’s findings.

Researchers highlight early diagnosis and tumour type differences as key factors improving outcomes in testicular cancer.

IURES 2025 study supports transperineal prostate biopsy under local anaesthesia as a safe, effective diagnostic option.

Researchers at IURES 2025 report seminal vesicle sampling enhances diagnostic accuracy in transperineal prostate biopsies.

A Taiwanese study finds that upper tract urothelial carcinoma patients with a history of urinary stones face worse cancer-specific and disease-free survival after surgery.

Largest real-world study shows ADT + ARPI improves persistence and survival in metastatic hormone-sensitive prostate cancer.

A new study finds the DR-70 protein may help detect bladder cancer early and assess disease severity, offering a promising tool for patient care.

New study finds COVID-19 temporarily lowers sperm quality but recovery occurs within months. Learn how infection affects male fertility and recovery timelines.

After eight years, overall survival reached 78.9% in the combination group, compared with 69.5% among those receiving leuprolide alone.

The Mediterranean diet was particularly effective in improving sexual function, likely through enhanced vascular health and reduced systemic inflammation.

Findings revealed a clear correlation between the resected prostate weight and improved voiding function.

A recent clinical study found that TURP + TUIBN improves symptom scores and quality-of-life outcomes in patients with small-volume BPH.

US-RASP has emerged as a promising alternative that maintains sexual function while providing comparable outcomes in urinary symptom relief.

Foley catheter placement sometimes masked symptoms, particularly in female patients, further complicating timely detection.

Financial challenges, comorbidities, and drug interactions may limit access, while systemic inequities contribute to racial and ethnic disparities.

A major European survey finds that one in three people cannot identify cystitis as a bladder infection and that half remain unaware women are most at risk.

The subtrigonal inlay patch buccal mucosal graft (SIP-BMG) technique represents one such advancement.

Several risk factors increase the likelihood of postoperative urinary retention, including general or opioid-based anaesthesia and underlying benign prostatic hyperplasia.

The IMPLEMENT study explored why first-line treatment intensification remains underutilised and how clinicians’ behaviours, beliefs, and environments influence its uptake.

The present study explored whether enhancing sampling density in the TZ could improve cancer detection.

The study found that virtual modalities are effective for the remote delivery of behavioural urinary incontinence treatment for women veterans.

Results revealed that women using the mobile app bladder training programme reported marked improvements in their quality of life, measured through the ICIQ-LUTSqol scale.

Recurrence rates remain a concern, with up to one third of men experiencing disease return within two years.

Recent advances in three-dimensional (3D) culture technology have transformed the way researchers study bladder cancer.

One promising approach targets nectin-4, a cell adhesion molecule linked to poor outcomes in several cancers, including bladder cancer.

A predictive scoring system, incorporating both current and prior PSA values, revealed that patients with persistently elevated levels had a very low likelihood, under 10%, of their PSA decreasing below the threshold at follow-up.

Black men remain underrepresented in large screening trials, and screening rates declined across all groups after the 2012 US Preventive Services Task Force recommendations.

nalysis of the BLADDA urothelial cancer registry demonstrated that neoadjuvant chemotherapy was associated with reduced risk of invasive bladder cancer recurrence.

Results showed that bpMRI was noninferior to mpMRI for detecting clinically significant prostate cancer, defined as Gleason Grade Group 2 or higher.

By aligning pretreatment risk stratification more closely with AS eligibility, clinicians may feel more confident recommending surveillance, potentially reducing overtreatment.

This study investigated the microbiota of the distal ileum in patients undergoing iRARC without bowel preparation, using direct sampling during ICUD.

Overall, this research offers a practical web-based prediction tool that can support clinicians in tailoring patient follow-up and treatment.

Integrating routine hormone testing with pelvic floor ultrasound assessments could help identify high-risk women early.

The model was subsequently applied to 11,723 examinations in men who had no documented diagnosis of prostate cancer at the time of MRI, with an average patient age of 65.5 years.

With limited early-detection tools and only modest improvements in survival for advanced disease, clinicians urgently need reliable biomarkers to improve prognostication.

Discover a study showing lasting survival gains from treatment intensification in prostate cancer.

Specialists have described the approval as one of the most promising developments in decades for bladder cancer care.

Study finds timing of mirabegron dosing affects symptom relief and emotional outcomes in women with overactive bladder.

The present study assessed the efficacy of sub-anaesthetic esketamine for CRBD prevention in patients undergoing ureteroscopic lithotripsy.

The TALAPRO-2 study enrolled 805 patients from 200 centres across 26 countries, including North America, Europe, Israel, South America, South Africa, and the Asia–Pacific region.

Taken together, the findings suggest that targeted augmentation of cholinergic signalling may help bridge the gap between anatomical de-obstruction and functional recovery in BOO-mediated UAB.

While MRI performance does not appear to depend on testosterone and inter-reader agreement is high, open questions remain, including whether PSMA PET or genomic markers could further refine early detection.

The authors hypothesised that, in women with OAB, the additional sympathetic blockade produced by spinal anaessthesia would further unmask parasympathetic dominance.

Researchers have developed a PSA-based index incorporating MRI measurements of periprostatic fat that significantly improves the prediction of high-grade prostate cancer.

Find out more about the role of platelet-to-lymphocyte ratio in improving prostate cancer detection.

AI-assisted autocontouring safely outlines organs for prostate radiotherapy, study finds—though manual edits are still needed for the prostate itself.

A major study shows that nearly 1 in 6 men with biopsy Grade Group 1 prostate cancer are at higher risk than previously assumed, with outcomes comparable to intermediate-grade disease.

Despite aggressive interventions, the five-year survival rate remains below 50% for those with localised disease and plummets to less than 15% when metastasis occurs.

Further analysis identified HDAC3 and the glucocorticoid receptor (GR) as key players in drug resistance.

The researchers suggest that the success of true auriculotherapy may be due to its influence on bladder control mechanisms, possibly via the vagus nerve.

A growing body of research supports non-pharmacological treatments, particularly exercise, as effective in alleviating primary dysmenorrhea symptoms.

A new study offers an innovative solution inspired by nature: soft dendritic particles (SDPs) that mimic the adhesive properties of gecko feet.

The study concludes that paediatric patients with cannabis use disorder may be at higher risk of developing a range of lower urinary tract symptoms compared to their peers without CUD.

Learn how TCM plus PDE5 inhibitors boosts erectile function in diabetes patients, with no extra side effects reported.

Discover a study revealing how chemotherapy-induced tumour pyroptosis reprograms fibroblasts, promoting chemoresistance in bladder cancer.

A new clinical study has identified a potential link between abnormal urinalysis and somatisation symptoms in female patients with epigastric pain syndrome.

Pelvic floor muscle training (PFMT) is recommended as an initial treatment for post-RP SUI, but traditional home-based approaches often lack long-term adherence.

From an economic perspective, urodynamics added £463 in cost and yielded a modest 0.011 additional quality-adjusted life-years.

Discover a study that reveals a targetable CA125+ cell state in rare bladder cancer subtypes using single-cell RNA sequencing.

Learn how EGF and UMOD levels may predict diabetic kidney disease progression, offering new tools for clinical risk assessment.

Non-muscle invasive bladder cancer, representing roughly 75% of cases, remains confined to the bladder lining and submucosa, often recurring but rarely advancing.

Patients treated on the entire prostate or surgical bed had better DMFS compared to those treated only on the relapse site.

Results showed that US overestimated bladder volumes compared to CBCT, with an average deviation of 60.75 ml.

Profiling urine tumour DNA at baseline and after 3 months of treatment could identify whether patients with bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer might not benefit from systemic immunotherapy.

These insights are particularly relevant in minimally invasive surgery, where precision and confidence are vital.

The GETSBI study is not only crucial for this specific patient group but also holds broader implications for research in rare, chronic conditions.

Preliminary outcomes indicated that AE may improve haemoglobin levels, possibly counteracting androgen deprivation therapy induced reductions.

The guidelines endorse adjuvant nivolumab for patients with pT3/4 and/or pN+ disease who are unsuitable for, or have declined, cisplatin-based chemotherapy.

Importantly, 30% mean reductions in prostate volume were sustained up to 18 months post-procedure.

Insomnia appeared in 61%, cognitive impairment and irritability in 38%, and more severe psychiatric issues such as psychosis and delirium were rarely considered.

Discover a recent study that found that smoking is associated with worse sexual function outcomes following radical prostatectomy.

Students using ChatGPT alone scored lower than those attending lectures suggesting that AI tools may not sufficiently support complex learning.

Discover a study where a checklist facilitated closed-loop management, ensuring continuity of care despite environmental changes.

Discover a study where researchers introduced a conceptual design for a toilet-mounted home device capable of non-invasively measuring urine flow, volume, and frequency.

This clinical trial evaluated the safety of stereotactic body radiotherapy to the prostate bed following radical prostatectomy.

The study analysed data from 1,757 urine samples collected as part of the Swiss Kidney Project on Genes in Hypertension (SKIPOGH).

Discover a study that found that 22% of patients who underwent radical cystectomy were upstaged at surgery, leading to a lower 12-month progression-free survival rate.

The proportion of radical prostatectomies ending in pGG1 fell from 32.4% in 2010 to just 7.8% by 2020

The investigation began with a comparison between 3,716 PCa patients from Johns Hopkins University, Baltimore, Maryland.

he analysis also highlighted that treatment intensification with enzalutamide benefited patients regardless of baseline PSA.

Gill described the event as a “historic moment in medicine,” potentially transforming treatment options for patients.

Discover a study that has demonstrated the potential of using AI to predict jaundice by analysing scleral images and urine colour.

Despite limitations, this review offers a foundational overview of the capabilities and challenges of next-generation robotic systems.

Researchers explored the effectiveness of combining biofeedback training with osteopathic techniques to improve outcomes in children with urinary incontinence.

The study aimed to assess the risk of IED following urologic procedures with or without antibiotic prophylaxis.

Findings suggest that both TPTNS and rTMS may have value in symptom management and quality-of-life improvement in MS patients with neurogenic OAB.

The analysis included patient-reported symptoms from treatment initiation to cycle 12 of pembrolizumab.

Early results support the theory that combining systemic and localised treatment in oligometastatic prostate cancer can improve tumour control.

Discover a recent study that has provided crucial new insights into the treatment of upper tract urothelial carcinoma.

Commensal bacteria from the gut, urinary tract, and prostate tissue may play an unexpected role in the progression of prostate cancer.

New data from PUrE RCT 1 reveals no difference in quality-of-life between patients treated with ESWL or FURS for ≤10 mm LPSs.

Hydrogel safer but less satisfying than mesh in long-term stress incontinence treatment, study finds.

This pioneering study provides valuable insights into dietary assessment techniques in older adults with sarcopenia.

In comparison with other established biomarkers, such as the free/total PSA ratio and PSA density, Stockholm3 outperformed these tests.

Volatile anaesthetics and propofol show no significant difference in intraoperative urine output, study suggests.

Pyramidal and threshold training boost endurance in cancer survivors, with threshold requiring less time.

The study demonstrated that the use of microultrasonography-guided biopsy could provide an alternative to MRI.

Discover how individualised treatment for febrile UTIs lowers antibiotic use and reduces adverse events in children.

Though urodynamics altered the diagnosis in 13% of women this did not translate to improved outcomes.

VEIL outperforms OIL in reducing complications and recovery time in penile cancer surgery, offering notable clinical benefits.

The study found that 74 of these participants would not have been identified through the UK’s current diagnostic pathway.

The findings revealed that total radiographic disappearance of metastases occurred in 15% of patients.

Transperineal prostate biopsies offer higher accuracy in repeat biopsy cases and reduced infection risks.

NeuroSAFE-guided prostate surgery significantly improves erectile function and urinary continence recovery compared to standard methods.

Oral oestrogen increases the risk of overactive bladder in women under 65.

A study reveals that proteinuria in young adults is linked to a significantly higher risk of sudden cardiac arrest.

A randomised pilot study investigated whether scheduled IV acetaminophen administration would offer longer-lasting relief than a single dose.

Recent research suggests that precision treatment may improve outcomes in prostate cancer treatment.

Discover how isodose MHFRT offers comparable cancer control to CFRT with fewer gastrointestinal side effects, improving patient outcomes.

Micro-ultrasound matches MRI in prostate cancer detection, offering faster, cheaper diagnosis.

TB vaccine boosts immunity in bladder cancer patients, all cancer-free after 5 years.

Waterjet surgery preserves ejaculation in 85% of patients with benign prostatic hyperplasia . Laser alternatives lag at 23%.

A new study suggests heated lidocaine gel combined with periprostatic nerve block reduces pain during prostate biopsy without increasing complications.

Smart t-shirt enables earlier discharge after urological cancer surgery, improving patient comfort and reducing hospital stays.

Notably, AI-driven models outperformed traditional clinical risk calculators like the EORTC and EAU models.

Index-based dietary patterns were not linked to PCa-specific mortality, though associations varied by race and ethnicity.

Processed foods and fast foods, which are high in unhealthy fats and low in fibre, were also found to exacerbate pelvic floor disorder symptoms.

Recent research comparing laparoscopic and open radical prostatectomy outcomes shows that radical prostatectomy leads to shorter hospital stays.

The primary treatment for intermediate and high-risk NMIBC includes transurethral resection of the bladder tumour.

New research shows that at-home prostate cancer tests are producing inconsistent and inaccurate results.

A study of 666 localised prostate tumours identified 223 driver regions, many influenced by structural variations undetectable via targeted sequencing.

Lower oestradiol and FSH levels are linked to renal cell carcinoma, highlighting potential hormonal influences on tumour progression.

The results suggest trends towards overall survival and progression-free survival improvements with pembrolizumab in combination with platinum-based chemotherapy.

Danish study finds anticholinergic bladder drugs linked to dementia risk, but not when compared to mirabegron.

The combination of durvalumab and tremelimumab with concurrent radiotherapy is a feasible and safe treatment strategy.

A recent study comparing the efficacy of mirabegron and solifenacin in children with overactive bladder revealed that both treatments were equally effective.

The results showed that the music group experienced significantly less pain, with a median VAS score of 3.6 compared to 5.4.

These findings suggest that strategies targeting visceral fat reduction may aid in overactive bladder management.

Ultimately, these findings highlight the potential for urinary DNA methylation testing to improve early detection and diagnosis of bladder cancer.

Blocking GDF-15 with visugromab enhances immune checkpoint therapy, offering new hope for resistant advanced cancers.

Researchers aimed to establish a plasma ctDNA sequencing assay and evaluate its effectiveness in assessing tumour genetics and treatment response.

By offering a non-invasive, highly specific approach, MyProstateScore 2.0 enhances clinical decision-making while reducing patient burden.

Extended pelvic lymph node dissection during prostatectomy significantly reduces metastasis risk, new study finds.

Women who are overweight with refractory overactive bladder respond better to botulinum toxin injections than pharmaceutical therapy, new research finds.

These findings suggest that the reduction in PSA screening has had a widespread impact.

Findings reveal that patients receiving induction chemotherapy before radical nephroureterectomy experienced significantly improved pathological downstaging.

Benign urological conditions are also influenced by climate change as research indicates a correlation between rising temperatures and dehydration-related conditions.

A new study has identified pathogenic variants in WNT9B as significant risk factors for hereditary prostate cancer.

Black males have the highest incidence and mortality rates for prostate cancer in the USA, but their participation in clinical trials remains disproportionately low.

A high calcium-to-magnesium ratio predicts nephrolithiasis in primary hyperparathyroidism, offering enhanced diagnostic accuracy and specificity.

Recent advancements in near-infrared fluorescence imaging have revolutionised lymph node tracing in cancers such as breast and penile cancers.

Recent advancements in ejaculation-preserving techniques during HoLEP have yielded encouraging results.

Problem-based learning is a student-centred teaching method that encourages learners to independently explore and solve real-world problems.

The findings demonstrated that the novel drug-injectable urethral catheter set with hyaluronic acid significantly reduced pain and increased patient satisfaction.

In a recent double-blind clinical trial, S. miltiorrhiza extract improved LUTS-related quality of life scores comparably to existing drugs, with notable safety advantages.

A recent study introduced a novel approach combining preoperative 3D printing with intraoperative ultrasound-guided puncture to address challenges in neurogenic bladder surgery.

In the RAIDER trial, 82% of patients received dose-escalated radiotherapy and experienced minimal late toxicity.

A recent study revealed that interstitial cystitis patients were older, predominantly female, and exhibited more severe symptoms.

These findings suggest that testosterone therapy can be safely administered to carefully selected men following radical prostatectomy without increasing the risk of biochemical recurrence.

Use of MRI as a first step in prostate cancer detection is safe and effective for at least three years, study finds.

Consuming grape juice at least 5 times per week may reduce the risk of erectile dysfunction, especially in men over 40 years old.

An AI model using XGBoost offers a non-invasive, high-accuracy method to diagnose prostate cancer in patients with PSA levels under 20 ng/ml.

A new ureteroscope shows promise in reducing infection risks and improving outcomes for patients with ureteric stones.

New research provides valuable insights into the urinary and intestinal microbiomes of individuals with spina bifida, a condition associated with an increased risk for UTIs.

New imaging technique has shown that many cases of prostate cancer may be more advanced than conventional imaging suggests.

Recent research sheds light on a promising therapeutic strategy for tackling prostate cancer by targeting the integrated stress response kinase GCN2.

Recent research has unveiled the crucial role of Androgen Response Elements in governing androgen receptors growth-suppressive transcriptional programs.

Despite promising preclinical and epidemiological data, metformin does not appear to impact disease progression in men with low-risk prostate cancer.

Stockholm3 demonstrates significant potential to enhance prostate cancer detection in diverse populations while maintaining similar sensitivity to PSA.

The study supports the potential of neoadjuvant androgen deprivation therapy as an adjunctive therapy in HRLPC, particularly for select subgroups with favourable biomarkers.

Baduanjin consists of eight simple, flowing movements focusing on deep breathing, muscle relaxation, and mindful awareness.

Logistic regression analysis revealed that patients receiving MRI-guided stereotactic body radiotherapy had significantly lower odds of experiencing clinically relevant deterioration.

Results demonstrated that the Ki-67 index decreased in the low omega-6 fatty acid diet supplemented with fish oil capsules group by approximately 15% from baseline to one year.

The introduction of rapid access prostate clinics aimed to streamline referrals and improve diagnosis.

Intravenous lidocaine can significantly reduce catheter-related bladder discomfort and postoperative pain in patients undergoing complex lumbar spinal surgery.

High-dose vitamin D supplementation significantly improves voiding frequency and other symptoms in children with overactive bladder

AI is revolutionising prostate cancer diagnostics by enhancing imaging accuracy and reducing interoperator variability.

Blockages are the most frequent complication, occurring in up to 70% of long-term catheter users.

Recent years have seen the international standard of care for mHSPC evolve to include androgen-deprivation therapy combined with docetaxel.

A recent study evaluated PCR against conventional culture and sensitivity in diagnosing and managing complicated UTIs.

Clinical studies have demonstrated the durability of prostatic artery embolisation’s benefits over time.

A recent randomised trial evaluated the efficacy and safety of combination therapy in women with overactive bladder.

At 6 weeks, 65% of men achieve azoospermia, while 70–73% reach this milestone between weeks 10–16.

In women with recurrent UTIs, increasing water intake by 1500 mL daily reduced the number and frequency of infections.

Evidence from multiple studies and randomised controlled trials suggests that robot-assisted radical cystectomy delivers improved perioperative outcomes.

Real-world data underline that only a minority of patients complete the recommended 4–6 chemotherapy cycles.

Predictive biomarkers are expected to play a pivotal role in further enhancing treatment outcomes as they can identify patients at higher risk of recurrence.

A recent clinical trial explored the efficacy of combining pembrolizumab, an anti-PD-1 immunotherapy, with standard platinum-based chemotherapy.

Postoperative neurogenic bladder significantly impacts patients’ quality of life, necessitating prolonged catheter use in up to 16% of cases.

Recent data shows a significant increase in germline genetic testing for prostate cancer, with a notable rise in urologist involvement.

A recent study examining prostate cancer treatments within the US Department of Veterans Affairs health system has raised concerns about overtreatment, particularly among men with limited life expectancy.

The study revealed that patients treated for prostate cancer, particularly with radiotherapy, have an elevated risk of developing several severe complications.

New research has revealed potential links between agricultural pesticide exposure and higher rates of prostate cancer among men in the USA.

A randomised clinical trial found that pressure-mediated biofeedback used as an adjunct to supervised pelvic floor muscle training improves postpartum stress urinary incontinence.  

A recent study reveals that too few patients with abnormal urine protein dipstick test results undergo the recommended follow-up albumin-to-creatinine ratio testing to confirm albuminuria.

Androgen deprivation therapy has been the cornerstone of treatment for advanced castration-sensitive prostate cancer for over fifty years.

In this study, researchers explored the potential of using cell-free RNA in urine as a noninvasive biomarker for genitourinary diseases.

A recent single-centre, randomised, trial has explored the effects of a 24-hour perioperative antibiotic course for patients undergoing cystectomy.

Prostate cancer remains a significant health concern for men, particularly those aged between 50 and 60 years.

A cohort study has explored the link between diet and the risk of prostate cancer grade reclassification in men diagnosed with grade group (GG) 1 disease undergoing active surveillance.

A study has provided new insights into testosterone recovery following androgen deprivation therapy in men undergoing radiotherapy for prostate cancer.

Prostate cancer is the second leading cause of cancer death worldwide among men, yet recent research suggests many early-stage prostate changes may not require a cancer diagnosis.

Researchers have validated the prognostic value of PSMA-PET findings using PROMISE criteria to predict overall survival in prostate cancer patients

A new technique for collecting prostate biopsy samples reduced the risk of infection compared with traditional biopsy approaches

Research highlights the significance of universal germline genetic testing in uncovering pathogenic germline variants across various genitourinary malignancies.

A recent cohort study has shed light on the potential benefits of plant-based diets for men diagnosed with prostate cancer

A new trial has evaluated and personalised treatments for metastatic castration-resistant prostate cancer, representing a major advancement in treatment options for the disease.

A study comparing pelvic floor yoga and general exercise found both effective in reducing urinary incontinence in women, with no significant difference between the two approaches.

A new classification system for Peyronie’s disease, has been introduced in a recent study aiming to better define the subtypes and stages of this condition

A study has suggested that generative AI tools could potentially reduce the time burden of electronic health record management for urologists.

A study shows that 8% of men with Gleason Grade Group 1 prostate cancer may have more aggressive disease. High PSA levels and extensive positive biopsy results are key risk factors.

A study has developed an AI model capable of predicting male infertility risk using hormone levels from a blood test.

Overactive bladder prevalence has increased by 28% in men according to a new study.

An at-home spit test could be more accurate than the standard blood test at predicting men who are at a higher risk of developing prostate cancer according to results from a study.

Germline pathogenic variants significantly impact survival outcomes in metastatic hormone-sensitive prostate cancer, highlights worse survival in patients with these genetic mutations.

A recent study has linked neighbourhood disadvantage to higher risks of stress-related gene expression in prostate tumours.

A new study has developed and validated a 15-gene expression-based biomarker that could facilitate risk stratification for clear cell renal cell carcinoma.

Prostate-specific antigen screening may miss early-stage prostate cancer in transgender women undergoing oestrogen therapy, according to new research.

Significant cardiovascular risks associated with adding androgen receptor signalling inhibitors to standard androgen deprivation therapy in patients with advanced prostate cancer.

New research has shown that an AI system can more efficiently detect clinically significant prostate cancer on MRI compared to radiologists.

Hematuria and urinary symptoms associated with radiation-induced cystitis are reduced with hyperbaric oxygen treatment, according to new research

A study in Taiwan identifies key predictive factors for recurrent urinary tract infections and other urological complications in chronic spinal cord injury patients

Active surveillance is an effective management strategy for males with favourable-risk prostate cancer, according to recent findings.

A study suggests that shockwave lithotripsy offers similar kidney stone clearance rates to ureteroscopy.

According to a study, there is insufficient evidence for the effective treatment of postmenopausal urinary incontinence

A team of researchers has created a new tool to assess the sexual health of female partners of patients with prostate cancer

A recent subgroup analysis has provided crucial insights into the safety of extended lymph node dissection.

A randomised clinical trial has found that D-mannose does not live up to its promise.

A retrospective review reveals brachytherapy may elevate long-term pelvic second malignancy risk compared to radical prostatectomy, urging continued screening and education.

The ProScreen trial introduces a three-step prostate cancer screening method, offering potential to detect aggressive cancers while reducing unnecessary diagnoses. Read more.

Racial disparities continue to affect patient outcomes following a diagnosis of prostate cancer. A recent study finds Black males with prostate cancer have worse microvascular function than White males, potentially heightening cardiovascular disease risk.

A new research finds urinary microbiomes with fewer Lactobacilli and higher bacterial diversity are linked to more severe urinary incontinence episodes in women. Read more.

The ProBE-PC randomised clinical trial set out to determine the efficacy of transrectal biopsy versus transperineal biopsy in detecting clinically significant prostate cancer, infectious complications, and toxicity.

Pregnancy and childbirth have been shown not to increase the risk of recurrence of stress urinary incontinence (SUI), despite common belief amongst clinicians. Read more.

Increasing evidence suggests that diet plays a critical role in overactive bladder management, and this is expected to shape decision-making and guidance provided in clinical practice in the near future.

New research analyses outcomes in males over and under 50 years of age with penile cancer. This investigation highlights the importance of public awareness and patient education for disease prevention, early detection, and management in the near future.

According to new research, a plant-based diet is linked to greater quality of life among patients treated for prostate cancer, with reported improvements in sexual function, urinary health, and hormone health.

According to researchers from the University of California San Diego (USCD), USA, pre-operative C-reactive protein levels can improve prediction of partial nephrectomy outcomes.

Detection of prostate cancer at first biopsy, and likelihood of prostate cancer detection, has been discovered to be consistently higher in Black patients compared to their White counterparts.

Detected on MRI, increased prostatic urethral length has been shown to increase risk of adverse events following radiation therapy for prostate cancer. Read more.

An observational study from the University of California, San Francisco, USA discovered that one option for treating high-risk localised prostate cancer showing favourable survival outcomes is radical prostatectomy.

According to recent research, using wet wipes to clean patients with catheters who are bedridden leads to fewer catheter-associated urinary tract infections. Read more.

New research suggests that patients with prostate cancer treated with radiotherapy may have an increased risk of developing bladder cancer or lung cancer.

We fondly remember Linda Cardozo OBE, Professor of Urogynaecology, and Consultant Gynaecologist at King’s College Hospital, London, UK.

Favourable survival outcomes have been discovered with neoadjuvant immunotherapy in patients with muscle-invasive bladder cancer…

Twice-daily cephalexin has been found as effective as a regimen of four daily doses, when treating females with uncomplicated UTI…

Vaginal estrogen is standard for UTIs in hypoestrogenic females, but the literature is limited. Read to find out more.

Radical prostatectomy is used to treat approximately 40% of patients with localised prostate cancer. Read more.

Study data has revealed that, despite its use in routine practice for prostate cancer diagnosis and staging, multiparametric MRI (mpMRI) is not effective at accurately staging localised prostate cancer…